Medicare Enrolled
Dr. Jeffrey Parres, MD
Urology Physician · Maryville, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parres from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parres?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parres
Dr. Jeffrey Parres is an urology physician in Maryville, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Parres performed 3,444 Medicare services across 2,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parres received a total of $8,305 from 51 pharmaceutical and/or device companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parres is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in IL
$8,305 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,444
Medicare services
Top 27% in IL for urology physician
2,363
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~172 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
609 | $59 | $247 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
560 | $2 | $10 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
357 | $49 | $127 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 175 | $132 | $700 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
159 | $84 | $313 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
137 | $8 | $15 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
124 | $0 | $1 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
118 | $37 | $96 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $168 | $722 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
110 | $48 | $125 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
106 | $7 | $38 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
101 | $4 | $30 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
74 | $188 | $746 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
74 | $11 | $115 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
73 | $112 | $427 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
71 | $76 | $301 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $113 | $377 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
39 | $24 | $101 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
38 | $103 | $391 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
37 | $440 | $1,651 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $61 | $218 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
30 | $186 | $666 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
28 | $242 | $876 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $43 | $172 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
26 | $103 | $1,128 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
26 | $77 | $261 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
24 | $48 | $181 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
24 | $203 | $1,079 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $129 | $453 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $301 | $1,349 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $92 | $298 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
17 | $35 | $106 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $141 | $413 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
12 | $284 | $1,029 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
10.5% medium
87.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,305
Total received (2018-2024)
Avg $1,186/year across 7 years
Top 21% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
264
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,141 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,415
2023
$2,710
2022
$928
2021
$847
2020
$684
2019
$749
2018
$973
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$209
UROGEN PHARMA, INC.
$178
Sumitomo Pharma America, Inc.
$159
Ferring Pharmaceuticals Inc.
$134
ACCORD HEALTHCARE, INC.
$131
Dendreon Pharmaceuticals LLC
$123
PFIZER INC.
$101
Bayer Healthcare Pharmaceuticals Inc.
$91
Myriad Genetic Laboratories, Inc.
$58
Astellas Pharma US Inc
$57
Janssen Biotech, Inc.
$53
Boston Scientific Corporation
$33
Telix Pharmaceuticals
$30
PROGENICS PHARMACEUTICALS, INC.
$24
VERTEX PHARMACEUTICALS INCORPORATED
$21
Laborie Medical Technologies Corp.
$14
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,416
Myriad Genetic Laboratories, Inc.
$702
Astellas Pharma US Inc
$593
Rochester Medical Corporation
$471
ACCORD HEALTHCARE, INC.
$415
KARL STORZ Endoscopy-America
$409
Janssen Biotech, Inc.
$396
Sumitomo Pharma America, Inc.
$342
PFIZER INC.
$257
Teleflex LLC
$240
Ferring Pharmaceuticals Inc.
$214
PROCEPT BioRobotics Corporation
$209
Progenics Pharmaceuticals, Inc.
$186
NeoTract Inc.
$186
UROGEN PHARMA, INC.
$178
Myovant Sciences Inc.
$146
Olympus America Inc.
$129
Antares Pharma, Inc.
$129
Allergan, Inc.
$125
Endo Pharmaceuticals Inc.
$124
Dendreon Pharmaceuticals LLC
$123
C. R. Bard, Inc. & Subsidiaries
$114
Bayer Healthcare Pharmaceuticals Inc.
$109
UROVANT SCIENCES INC
$108
BOSTON SCIENTIFIC CORPORATION
$107
Intuitive Surgical, Inc.
$75
Bayer HealthCare Pharmaceuticals Inc.
$72
Lumenis, Inc
$71
Allergan Inc.
$64
Novartis Pharmaceuticals Corporation
$60
Acerus Pharmaceuticals Corporation
$54
PALETTE LIFE SCIENCES, INC.
$51
Travere Therapeutics, Inc.
$44
UroGen Pharma, Inc.
$38
Telix Pharmaceuticals
$30
Janssen Pharmaceuticals, Inc
$27
Laborie Medical Technologies Corp.
$26
Avadel Specialty Pharmaceuticals, LLC
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Merck Sharp & Dohme LLC
$23
Palette Life Sciences, Inc.
$22
VERTEX PHARMACEUTICALS INCORPORATED
$21
Retrophin, Inc.
$20
Medtronic USA, Inc.
$18
Clarus Therapeutics Inc.
$18
Cook Incorporated
$17
Shire North American Group Inc
$17
TOLMAR Pharmaceuticals, Inc.
$17
Kowa Pharmaceuticals America, Inc.
$16
Merck Sharp & Dohme Corporation
$16
Cook Medical LLC
$15
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMBICOR · AMS · AMS 700 · AQUABEAM SYSTEM · AVEED · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · BRIDION · Bard Urinary Drainage Bag · CAMCEVI · COOK MEDICAL STENTS · CUSTOM CONTRACT CAM UROLOGY · Cook Medical Stents · Da Vinci Surgical System · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · Flex-X / IMAGE 1 S · GATTEX · GEMTESA · GENERAL THERAPIES · GENERAL - KIDNEY STONE DISEASE · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · Lumenis Pulse 120H · MAGIC3 · MYRBETRIQ · Moses 550 D\F\L · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SPACEOAR · Seglentis · TOVIAZ · TRADE PROMO: SPIES FLEXC · Thiola · URETERO-RENO-FIBERSCOPE FLEX-X · UROLIFT · US DEFL · UroLift · UroLift System · WECK EFx Shield Port Site Closure System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
71
Per 100K population
26.8
County median income
$74,800
Nearest hospital
ANDERSON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parres is a clinical cardiology specialist, with above-average Medicare volume (top 27% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parres experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Parres performed 609 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parres receive payments from pharmaceutical companies?
Yes. Dr. Parres received a total of $8,305 from 51 companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parres's costs compare to other urology physicians in Maryville?
Dr. Parres's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parres) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Maryville
Browse urology physicians in Maryville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology